Laboratory Corporation of America Holdings
LH
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, bloodā¦ read more
Healthcare
Diagnostics & Research
35 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$273.61
Price+1.46%
$3.94
1Y
Price
Market Cap
$22.682b
Large
Price/Earnings 3y Avg5y Avg
26.2x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+15.8%
EBITDA Margin+7.3%
Net Profit Margin+7.9%
Free Cash Flow Margin+15.8%
EBITDA Margin+7.3%
Net Profit Margin+7.9%
Free Cash Flow MarginRevenue
$13.952b
+5.8%
1y CAGR+5.1%
3y CAGR+1.4%
5y CAGREarnings
$876.500m
+14.6%
1y CAGR+8.6%
3y CAGR-5.1%
5y CAGREPS
$10.46
+15.2%
1y CAGR+11.6%
3y CAGR-2.0%
5y CAGRBook Value
$8.637b
$18.393b
Assets$9.756b
Liabilities$7.204b
DebtDebt to Assets
39.2%
3.2x
Debt to EBITDAFree Cash Flow
$1.206b
+26.0%
1y CAGR+3.6%
3y CAGR-8.4%
5y CAGRNo items found.
Press Releases
Statements and updates from the company